EMETIC EFFECTS OF ANTICANCER DRUGS AND INVOLVEMENT OF VISCERAL AFFERENT-FIBERS AND 5-HT3 RECEPTORS IN DOGS

被引:10
作者
FUKUI, H
YAMAMOTO, M
SASAKI, S
SATO, S
机构
[1] Drug Safety Research Laboratories, Takeda Chemical Industries, Ltd., Takatsuki, Osaka, 569
关键词
ANTICANCER DRUG-INDUCED VOMITING; 5-HT3 RECEPTOR ANTAGONIST; VISCERAL AFFERENT;
D O I
10.1016/0014-2999(93)90392-U
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The emetic effects of five anticancer drugs, cyclophosphamide, nitrogen mustard-N-oxide, actinomycin D, 5-fluorouracil and L-asparaginase, and the effects of bilateral abdominal vagotomy and bilateral greater splanchnic nerve section or a 5-HT3 receptor antagonist on the emesis induced by these drugs were investigated in dogs. Cyclophosphamide (20 mg/kg, i.v.), nitrogen mustard-N-oxide (5 mg/kg, i.v.) and actinomycin D (50 mug/kg, i.v.) caused vomiting in dogs with a long latency period. 5-Fluorouracil (5 mg/kg, i.v.) and L-asparaginase (2000 K.U./kg, i.v.) failed to induce vomiting. Bilateral abdominal vagotomy and bilateral greater splanchnic nerve section completely inhibited the vomiting induced by the former three anticancer drugs. Furthermore, the vomiting was inhibited completely by intravenous administration of ICS205930 (2 x 0.1 mg/kg), a 5-HT3 receptor antagonist. These results suggest that activation of visceral afferents through 5-HT3 receptors mediates the vomiting induced by cyclophosphamide, nitrogen mustard-N-oxide and actinomycin D.
引用
收藏
页码:281 / 287
页数:7
相关论文
共 49 条
[31]   EMESIS INDUCED BY CANCER CHEMOTHERAPEUTIC-AGENTS IN THE SUNCUS-MURINUS - A NEW EXPERIMENTAL-MODEL [J].
MATSUKI, N ;
UENO, S ;
KAJI, T ;
ISHIHARA, A ;
WANG, CH ;
SAITO, H .
JAPANESE JOURNAL OF PHARMACOLOGY, 1988, 48 (02) :303-306
[32]  
MCCARTHY LE, 1984, CANCER TREAT REP, V68, P401
[33]   VAGAL-INDUCED VOMITING IN DECEREBRATE CAT IS NOT SUPPRESSED BY SPECIFIC 5-HT(3) RECEPTOR ANTAGONISTS [J].
MILANO, S ;
GRELOT, L ;
CHEN, Z ;
BIANCHI, AL .
JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM, 1990, 31 (02) :109-118
[34]  
MILLER AD, 1992, J PHARMACOL EXP THER, V260, P509
[35]   INHIBITION OF CISPLATIN-INDUCED VOMITING BY SELECTIVE 5-HYDROXYTRYPTAMINE M-RECEPTOR ANTAGONISM [J].
MINER, WD ;
SANGER, GJ .
BRITISH JOURNAL OF PHARMACOLOGY, 1986, 88 (03) :497-499
[36]   PHARMACOLOGICAL AGENTS AFFECTING EMESIS - A REVIEW .1. [J].
MITCHELSON, F .
DRUGS, 1992, 43 (03) :295-315
[37]   CISPLATIN-INDUCED EMESIS IN SUNCUS-MURINUS [J].
MUTOH, M ;
IMANISHI, H ;
TORII, Y ;
TAMURA, M ;
SAITO, H ;
MATSUKI, N .
JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 58 (03) :321-324
[38]   THE 5-HT3 RECEPTOR LIGAND, [H-3] BRL 43694, BINDS TO PRESYNAPTIC SITES IN THE NUCLEUS TRACTUS SOLITARIUS OF THE RAT [J].
PRATT, GD ;
BOWERY, NG .
NEUROPHARMACOLOGY, 1989, 28 (12) :1367-1376
[39]   AUTORADIOGRAPHIC LOCALIZATION OF 5-HT3 RECEPTOR LIGAND-BINDING IN THE CAT BRAIN-STEM [J].
REYNOLDS, DJM ;
LESLIE, RA ;
GRAHAMESMITH, DG ;
HARVEY, JM .
NEUROCHEMISTRY INTERNATIONAL, 1991, 18 (01) :69-73
[40]   CISPLATIN-EVOKED INDUCTION OF C-FOS PROTEIN IN THE BRAIN-STEM OF THE FERRET - THE EFFECT OF CERVICAL VAGOTOMY AND THE ANTIEMETIC 5-HT3 RECEPTOR ANTAGONIST GRANISETRON (BRL-43694) [J].
REYNOLDS, DJM ;
BARBER, NA ;
GRAHAMESMITH, DG ;
LESLIE, RA .
BRAIN RESEARCH, 1991, 565 (02) :231-236